100 studies found for:    Open Studies | "Vasculitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:
2 Unknown  Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Condition: Vasculitis
Intervention: Drug: azathioprine
3 Unknown  Alemtuzumab for ANCA Associated Refractory Vasculitis
Conditions: Vasculitis;   Microscopic Polyangiitis;   Granulomatosis With Polyangiitis;   Wegener's
Intervention: Drug: Alemtuzumab
4 Recruiting CMV Modulation of the Immune System in ANCA-associated Vasculitis
Conditions: ANCA Associated Vasculitis;   CMV Infection
Intervention: Drug: Valaciclovir
5 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
6 Recruiting IgA-positive Versus IgA-negative Immune Complex Vasculitis
Condition: Cutaneous Vasculitis
Intervention:
7 Not yet recruiting Endothelin Antagonism in ANCA Vasculitis
Condition: Vasculitis
Intervention: Drug: BQ123 or BQ123/788
8 Recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine
9 Not yet recruiting Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
Conditions: ANCA-associated Vasculitis;   Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   EosinphilicGranulomatosis With Polyangiitis
Intervention:
10 Recruiting Optical Coherence Tomography (OCT) in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
11 Recruiting Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiS
Condition: Systemic Vasculitis
Interventions: Device: Ultrasound;   Device: MRA
12 Recruiting Belimumab in Remission of VASculitis
Condition: Vasculitis
Interventions: Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
13 Recruiting Positron Emission Tomography of Infection and Vasculitis
Conditions: Infection;   Vasculitis
Intervention: Radiation: PET/CT
14 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Intervention: Biological: Hematopoietic Stem Cell Transplant
15 Unknown  Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
Conditions: Wegener's Granulomatosis;   Vasculitis
Interventions: Drug: mycophenolate mofetil;   Drug: cyclophosphamide
16 Not yet recruiting Low-dose Glucocorticoid Vasculitis Induction Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Drug: Rituximab;   Drug: Glucocorticoids
17 Recruiting A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Renal Vasculitis
Condition: Renal Vasculitis
Interventions: Drug: Placebo;   Drug: CCX168
18 Recruiting Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
Condition: ANCA-associated Vasculitis
Intervention:
19 Not yet recruiting Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Intervention: Other: Follow-up
20 Not yet recruiting Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Condition: ANCA-associated Primary Necrotizing Vasculitides
Interventions: Drug: Rosuvastatin;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years